The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Kyowa Hakko Kirin's 2012 Japan sales performance.
by Sciterion. for Kyowa Kirin. Multidisciplinary Management of CKD: A Global Perspective.
The European Medicines Agency’s (EMA) Comittee for Medicinal Products for Human Use (CHMP) has rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant, despite the treatment being approved in the ... with Parkinson’s, an area which has had few
execute a successful virtual launch if it is going to compete with drugs such as Inbrija (Acorda Therapeutics), Nourianz (Kyowa Kirin), and Ongentys (Neurocrine Biosciences).
by Kyowa Kirin. with support from Ann Taylor, Adam Winstock, Liz Gilligan, Adrian Brown, Anthony Gartland. ... guidance:. Kyowa Kirin had an experienced team with a wealth of knowledge of alcohol dependency who were working from home.
by Kyowa Kirin. with support from Ann Taylor, Adam Winstock, Liz Gilligan, Adrian Brown, Anthony Gartland. ... Supporting Alcohol Teams through the Global COVID19 Pandemic - by Kyowa Kirin.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...